China bio-manufacturing start-up Mojia raises $80m

Biotech-focused investor Lyzz Capital and Sento Investment also participated, while there were re-ups from agrifood tech-focused Bits x Bites and Asia Green Fund.

Founded in 2018, Mojia produces food ingredients and chemical materials - notably vitamin B5 - using renewable carbon sources and green processes. The prevailing industry manufacturing process is petroleum-based.

The company claims that its patented bio-process involving enzyme and metabolic engineering consumes less energy and emits less waste. It also ensures a more stable supply of vitamin B5, given the disruptions caused elsewhere by tighter enforcement of China's environmental regulations. 

Mojia is also working on a series of biopolymer products for coating and adhesive applications. The new funding will go towards product commercialisation, scaling up manufacturing capacity, pipeline development, and expanding global R&D capabilities.

"Our green technology has shown it is possible to address the environmental pollution associated with the traditional chemicals industry while achieving cost advantages and superior performance," said Ansen Chiew, co-founder of Mojia.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• Cleantech
• Greater China
• Early-stage
• Healthcare
• Industrials
• China
• Temasek Holdings
• Asia Green Fund